Neoadjuvant pyrotinib plus nab-paclitaxel, doxorubicin, and cyclophosphamide for HER2-positive locally advanced breast cancer: a retrospective case-series study
@article{GS86303, author = {De-Shun Yao and Wei Wang and Jin-Yi Chang and Yang Zhang and Hui-Wen Zhang and Jin-Xia Xu and Hai-Feng Cai}, title = {Neoadjuvant pyrotinib plus nab-paclitaxel, doxorubicin, and cyclophosphamide for HER2-positive locally advanced breast cancer: a retrospective case-series study}, journal = {Gland Surgery}, volume = {10}, number = {12}, year = {2021}, keywords = {}, abstract = {}, issn = {2227-8575}, url = {https://gs.amegroups.org/article/view/86303} }